Provided by Tiger Trade Technology Pte. Ltd.

CMS

11.050
+0.1501.38%
Volume:5.54M
Turnover:60.85M
Market Cap:26.88B
PE:15.35
High:11.110
Open:10.850
Low:10.810
Close:10.900
52wk High:15.195
52wk Low:9.354
Shares:2.43B
HK Float Shares:2.43B
Volume Ratio:0.59
T/O Rate:0.23%
Dividend:0.35
Dividend Rate:3.18%
EPS(LYR):0.720
ROE:8.42%
ROA:5.62%
PB:1.28
PE(LYR):15.35
PS:2.64

Loading ...

China Medical System files HKEX next-day return disclosing share buyback at HKD 10.55 each

Reuters
·
Jun 04

CMS Executes Share Buyback Valued at HK$9.69 Million on June 3

Stock News
·
Jun 03

CMS completes HK$9.69 million on-market buyback, treasury stock rises to 3.08 million shares

Bulletin Express
·
Jun 03

CMS Allocates HK$5.58 Million for Share Buyback on June 1

Stock News
·
Jun 01

CMS Cuts Outstanding Shares by 1.02 Million in May; Maintains Public Float Compliance

Bulletin Express
·
Jun 01

CMS Allocates Approximately HK$10.81 Million for Share Buyback on May 29

Stock News
·
May 29

China Medical System Gets China Trial Approval for Crohn's, Colitis Drug

MT Newswires Live
·
May 26

CMS Receives Regulatory Clearance for Clinical Trials of Novel TYK2 Inhibitor in Ulcerative Colitis and Crohn's Disease

Stock News
·
May 26

China Medical System Holdings - CMS-D001 Granted Drug Clinical Trial Approval by Nmpa on 25 May 2026

THOMSON REUTERS
·
May 26

AI Frenzy Shifts from Hardware to Applications, Musk-Related Concepts Gain Traction

Stock News
·
May 07

CMS (867.HK/8a8.SG) Signed an Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer® and Cosmofer®

THOMSON REUTERS
·
Apr 27

China Medical System Holdings - Pharmacosmos to Manufacture and Supply Monofer and Cosmofer for Fifteen Years

THOMSON REUTERS
·
Apr 27

China Medical System Holdings: Nda for Mg-K10 for Seasonal Allergic Rhinitis Accepted by Nmpa in China on April 23, 2026

THOMSON REUTERS
·
Apr 23

CMS Secures NMPA Nod to Review MG-K10 NDA for Once-Monthly Treatment of Seasonal Allergic Rhinitis

Bulletin Express
·
Apr 23

China Medical System shareholders approved RMB 0.1366 final dividend per share

Reuters
·
Apr 23

CMS Announces NMPA Acceptance of New Drug Application for MG-K10 in Seasonal Allergic Rhinitis

Stock News
·
Apr 23

China Medical System says China regulator accepts MG-K10 allergic rhinitis NDA

Reuters
·
Apr 23

China Medical System - New Drug Application for Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug Mg-K10 Accepted in China

THOMSON REUTERS
·
Apr 23

CMS Sets 23 Apr 2026 AGM; Proposes RMB0.1366 Final Dividend, 20% Issue Mandate and 10% Buy-back Authority

Bulletin Express
·
Apr 01

China Medical System Holdings announces annual general meeting notice

Reuters
·
Apr 01